Partnering with Novo Nordisk:
What is in it for you?
- An open and honest collaboration based on long-term commitment and mutual interest
- Access to world-class protein and peptide technology and development expertise
- Benefits of a global organisation that surpasses industry standards for developing proteins from molecule to market
Our partnerships are based on trust
At Novo Nordisk, we are committed to operating in a way that is financially, environmentally and socially responsible which we call our ‘triple bottom line’ approach to doing business. We enter partnerships with the same philosophy in mind.
Proteins are our core competency
For almost a century we have discovered, developed and marketed protein-based therapeutics. We continue to leverage our leading expertise in all aspects of designing, expressing, engineering, formulating and delivering proteins to develop new and innovative therapies for people with chronic diseases like diabetes, chronic inflammatory disorders and haemophilia.
Our focused approach also means that we have a clear R&D strategy. Therefore, our discussions with you will be directed towards seriously exploring if an alliance with you can help us both to reach our mutual goals faster and more effectively.
We have global reach
We have a global organisation with employees in 79 countries, including Denmark where we are headquartered. We have long-standing professional relationships with key opinion leaders and decision-makers in our main disease areas around the world and we work closely with them to develop, execute and communicate the clinical development of our products.
We conduct world-class research in target and drug discovery, as well as protein engineering at our R&D sites around the world: Seattle, USA; Beijing, China; Bangalore, India and at various sites around Copenhagen in Denmark, which also includes our applied diabetes research arm at the international Hagedorn Research Institute.
We believe success is in partnerships
Although we are experts in focused R&D areas, we also recognise the importance that partnering can play in securing successful pipeline development. No company will be able to sustain innovation without strategic collaborations with external partners, both in academia and industry.
Successful partnerships are based on mutual gain and trust. At Novo Nordisk, we have an internal alliance governance structure that is designed to ensure continuity and transparency throughout our partnerships. This governance is managed by our Corporate Alliance Management team, who are dedicated to securing the full value of each of our alliances over the long-term.
